MRC Laboratory of Molecular Biology
One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.
A study by Lalita Ramakrishnan, from the University of Cambridge Molecular Immunity Unit based in the LMB, has found that most people who fall seriously ill with tuberculosis do so within 2 years of getting infected, which has implications for public health strategy. More…
Yee Lian Chew and Bill Schafer, from the LMB’s Neurobiology Division, have made a video abstract to accompany their recent paper in Neuron. They describe how sensory responsiveness in worms is controlled by communication via neuropeptides. More…
LMB researchers are helping to transform parts of Cambridgeshire into centres of discovery with hands-on, family-friendly activities in shopping centres, cafes and public spaces. A full programme of events in Cambridge and Peterborough can be found on the LifeLab website. Book now! More...
Fabrice Gorrec, from the LMB’s crystallisation facility, is a finalist in the newly introduced Researcher of the Year category at the Cambridge Independent Science and Technology Awards 2018. The winners will be announced at a ceremony on 1st November. More…
Ribosome reader to Royal Society leader: a biologist’s road to the Nobel – Nature’s review of LMB group leader Venki Ramakrishnan’s account of his career. More…
In recent years, support has grown for the idea that the same aggregating protein can fold up into different toxic shapes, giving rise to distinct neurodegenerative diseases. Now, in the August 29 Nature, researchers led by Michel Goedert and Sjors Scheres at the MRC Laboratory of Molecular Biology in Cambridge, England, in collaboration with Bernardino Ghetti and colleagues at Indiana University School of Medicine in Indianapolis, provide the first molecular-level proof that this happens. More…